167 related articles for article (PubMed ID: 24424178)
1. Diagnosis and classification of autoimmune parathyroid disease.
Betterle C; Garelli S; Presotto F
Autoimmun Rev; 2014; 13(4-5):417-22. PubMed ID: 24424178
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
Alimohammadi M; Björklund P; Hallgren A; Pöntynen N; Szinnai G; Shikama N; Keller MP; Ekwall O; Kinkel SA; Husebye ES; Gustafsson J; Rorsman F; Peltonen L; Betterle C; Perheentupa J; Akerström G; Westin G; Scott HS; Holländer GA; Kämpe O
N Engl J Med; 2008 Mar; 358(10):1018-28. PubMed ID: 18322283
[TBL] [Abstract][Full Text] [Related]
3. Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism.
Brown EM
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):437-45, x. PubMed ID: 19328421
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against the calcium-sensing receptor and cytokines in autoimmune polyglandular syndromes types 2, 3 and 4.
Kemp EH; Kahaly GJ; Porter JA; Frommer L; Weetman AP
Clin Endocrinol (Oxf); 2018 Jan; 88(1):139-145. PubMed ID: 28941288
[TBL] [Abstract][Full Text] [Related]
5. Calcium-sensing receptor autoantibody-mediated hypoparathyroidism associated with immune checkpoint inhibitor therapy: diagnosis and long-term follow-up.
Dadu R; Rodgers TE; Trinh VA; Kemp EH; Cubb TD; Patel S; Simon JM; Burton EM; Tawbi H
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581059
[TBL] [Abstract][Full Text] [Related]
6. [Hypoparathyroidism associated with autoimmune disorder].
Yamauchi M; Sugimoto T
Clin Calcium; 2007 Aug; 17(8):1193-9. PubMed ID: 17660615
[TBL] [Abstract][Full Text] [Related]
7. Causes and pathophysiology of hypoparathyroidism.
Cianferotti L; Marcucci G; Brandi ML
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):909-925. PubMed ID: 30665552
[TBL] [Abstract][Full Text] [Related]
8. Hypoparathyroidism and autoimmune polyendocrine syndromes.
Schott M; Scherbaum WA
N Engl J Med; 2004 Sep; 351(10):1032-3; author reply 1032-3. PubMed ID: 15342816
[No Abstract] [Full Text] [Related]
9. Calcium-sensing receptor autoantibodies are relevant markers of acquired hypoparathyroidism.
Mayer A; Ploix C; Orgiazzi J; Desbos A; Moreira A; Vidal H; Monier JC; Bienvenu J; Fabien N
J Clin Endocrinol Metab; 2004 Sep; 89(9):4484-8. PubMed ID: 15356052
[TBL] [Abstract][Full Text] [Related]
10. The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex.
Gylling M; Kääriäinen E; Väisänen R; Kerosuo L; Solin ML; Halme L; Saari S; Halonen M; Kämpe O; Perheentupa J; Miettinen A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4602-8. PubMed ID: 14557429
[TBL] [Abstract][Full Text] [Related]
11. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism.
Kifor O; McElduff A; LeBoff MS; Moore FD; Butters R; Gao P; Cantor TL; Kifor I; Brown EM
J Clin Endocrinol Metab; 2004 Feb; 89(2):548-56. PubMed ID: 14764760
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy of autoimmune hypoparathyroidism in a patient with activating autoantibodies against the calcium-sensing receptor.
Chamberlin M; Kemp EH; Weetman AP; Khadka B; Brown EM
Clin Endocrinol (Oxf); 2019 Jan; 90(1):214-221. PubMed ID: 30358904
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism.
Li Y; Song YH; Rais N; Connor E; Schatz D; Muir A; Maclaren N
J Clin Invest; 1996 Feb; 97(4):910-4. PubMed ID: 8613543
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism.
Goswami R; Brown EM; Kochupillai N; Gupta N; Rani R; Kifor O; Chattopadhyay N
Eur J Endocrinol; 2004 Jan; 150(1):9-18. PubMed ID: 14713274
[TBL] [Abstract][Full Text] [Related]
15. Classification of Hypoparathyroid Disorders.
Cianferotti L
Front Horm Res; 2019; 51():127-138. PubMed ID: 30641517
[TBL] [Abstract][Full Text] [Related]
16. Late diagnosis of chronic hypocalcemia due to autoimmune hypoparathyroidism.
Teisseyre M; Moranne O; Renaud S
BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34193455
[TBL] [Abstract][Full Text] [Related]
17. Calcium-Sensing Receptor Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1: Epitopes, Specificity, Functional Affinity, IgG Subclass, and Effects on Receptor Activity.
Habibullah M; Porter JA; Kluger N; Ranki A; Krohn KJE; Brandi ML; Brown EM; Weetman AP; Kemp EH
J Immunol; 2018 Dec; 201(11):3175-3183. PubMed ID: 30381479
[TBL] [Abstract][Full Text] [Related]
18. Auto-immune hypoparathyroidism.
Weetman AP
Ann Endocrinol (Paris); 2015 May; 76(2):89-91. PubMed ID: 25913523
[No Abstract] [Full Text] [Related]
19. Activating Antibodies to The Calcium-sensing Receptor in Immunotherapy-induced Hypoparathyroidism.
Lupi I; Brancatella A; Cetani F; Latrofa F; Kemp EH; Marcocci C
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112105
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and clinical associations of calcium-sensing receptor and NALP5 autoantibodies in Finnish APECED patients.
Kemp EH; Habibullah M; Kluger N; Ranki A; Sandhu HK; Krohn KJ; Weetman AP
J Clin Endocrinol Metab; 2014 Mar; 99(3):1064-71. PubMed ID: 24423312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
